324 related articles for article (PubMed ID: 19118567)
1. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
[TBL] [Abstract][Full Text] [Related]
2. Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.
Graham RA; Tyler LO; Krol WL; Silver IS; Webster LO; Clark P; Chen L; Banks T; LeCluyse EL
J Biochem Mol Toxicol; 2006; 20(2):69-78. PubMed ID: 16615094
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes.
Price RJ; Giddings AM; Scott MP; Walters DG; Capen CC; Osimitz TG; Lake BG
Toxicology; 2008 Jan; 243(1-2):84-95. PubMed ID: 18022748
[TBL] [Abstract][Full Text] [Related]
4. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.
Hariparsad N; Carr BA; Evers R; Chu X
Drug Metab Dispos; 2008 Jun; 36(6):1046-55. PubMed ID: 18332078
[TBL] [Abstract][Full Text] [Related]
7. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
8. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
[TBL] [Abstract][Full Text] [Related]
9. Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures.
Pekthong D; Blanchard N; Abadie C; Bonet A; Heyd B; Mantion G; Berthelot A; Richert L; Martin H
Chem Biol Interact; 2009 May; 179(2-3):247-55. PubMed ID: 19041297
[TBL] [Abstract][Full Text] [Related]
10. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
11. Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes.
Szotáková B; Skálová L; Baliharová V; Dvorscáková M; Storkánová L; Sispera L; Wsól V
J Pharm Pharmacol; 2004 Feb; 56(2):205-12. PubMed ID: 15005879
[TBL] [Abstract][Full Text] [Related]
12. In vitro assays for induction of drug metabolism.
Lake BG; Price RJ; Giddings AM; Walters DG
Methods Mol Biol; 2009; 481():47-58. PubMed ID: 19096794
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting.
Jover R; Bort R; Gómez-Lechón MJ; Castell JV
Hepatology; 2001 Mar; 33(3):668-75. PubMed ID: 11230748
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice.
Sun G; Thai SF; Lambert GR; Wolf DC; Tully DB; Goetz AK; George MH; Grindstaff RD; Dix DJ; Nesnow S
Toxicol Lett; 2006 Jun; 164(1):44-53. PubMed ID: 16406388
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytochrome P450 enzymes in hepatic organoid reconstructed by rat small hepatocytes.
Miyamoto S; Hirata K; Sugimoto S; Harada K; Mitaka T
J Gastroenterol Hepatol; 2005 Jun; 20(6):865-72. PubMed ID: 15946133
[TBL] [Abstract][Full Text] [Related]
16. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.
Turpeinen M; Tolonen A; Chesne C; Guillouzo A; Uusitalo J; Pelkonen O
Toxicol In Vitro; 2009 Jun; 23(4):748-53. PubMed ID: 19328226
[TBL] [Abstract][Full Text] [Related]
17. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
[TBL] [Abstract][Full Text] [Related]
18. The olivacine derivative s 16020 (9-hydroxy-5,6-dimethyl-N-[2-(dimethylamino)ethyl)-6H-pyrido(4,3-B)-carbazole-1-carboxamide) induces CYP1A and its own metabolism in human hepatocytes in primary culture.
Pichard-Garcia L; Weaver RJ; Eckett N; Scarfe G; Fabre JM; Lucas C; Maurel P
Drug Metab Dispos; 2004 Jan; 32(1):80-8. PubMed ID: 14709624
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric acid (EMD 392949) in vivo and in vitro.
Richert L; Tuschl G; Viollon-Abadie C; Blanchard N; Bonet A; Heyd B; Halkic N; Wimmer E; Dolgos H; Mueller SO
Drug Metab Dispos; 2008 Apr; 36(4):702-14. PubMed ID: 18216275
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor.
Kakizaki S; Yamazaki Y; Kosone T; Horiguchi N; Sohara N; Sato K; Takagi H; Yoshinari K; Mori M
Liver Int; 2007 Feb; 27(1):109-19. PubMed ID: 17241389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
